diabetes

June 10 - IBM and Roche yesterday unveiled their co-created AI-driven solution - Roche's Accu-Chek SmartGuide Predict app - designed to optimize the daily management of diabetes. - designed to optimize the day-to-day management of diabetes. The solution emphasizes the importance of cross-industry collaboration and teamwork in supporting the daily lives of people with diabetes and the delivery of healthcare. The solution was launched in Switzerland a few months ago and served as a key example of digital innovation and cross-industry collaboration on June 5...

March 30, according to Xunfei medical news, the national "four major chronic diseases" major special core results -- the world's first "type 1 diabetes disease model" was officially released yesterday. It is said that this is a leap from the laboratory to the clinic, but also in Anhui Province in the field of chronic disease prevention and treatment for the first time to realize the results of national major scientific research projects. According to reports, the project focuses on type 1 diabetes diagnosis and treatment pain points, through the integration of multimodal data and clinical experience, based on the Xunfei Starfire medical model X1, constructed to cover the screening, typing, treatment and management of the whole chain of digital intelligence prevention and control system. 1AI from KU Xunfei official...

According to a local time report in the UK's Guardian newspaper on the 24th, the UK's National Health Service (NHS) will launch the world's first artificial intelligence trial using a "transformative" tool to identify patients at risk of developing type 2 diabetes more than a decade in advance. According to 1AI, more than 500 million people worldwide already have type 2 diabetes, and new ways to identify those at risk before they develop the disease have become a major global public health goal. It is predicted that by 2050, approximately 1 billion people worldwide will be affected by the disease. Type 2 diabetes is responsible for blindness, kidney failure, heart...

The MIFA Lab at Qingyuan Research Institute of Shanghai Jiao Tong University and the Department of Endocrinology at Zhongshan Hospital of Fudan University have formed a team of experts to develop a diabetes-specific macromodel called Diabetica. The Diabetica model can help patients, doctors, and healthcare organizations work together to address the complex challenges of diabetes management by combining the powerful language processing capabilities of the big model with expertise in the field of diabetes to provide all-around intelligent support for doctors, patients, and medical education. The team introduced a novel framework to train and validate diabetes-specific big language models. The team first developed ...